Successful immunomodulation in kidney transplant recipients with cytokine release syndrome after coronavirus disease

Successful immunomodulation in kidney transplant recipients with cytokine release syndrome after coronavirus disease

Introduction Patients with coronavirus disease, especially solid organ transplant recipients, are more susceptible to developing cytokine release syndrome than those with other viral infections. However, currently, treatment methods for such patients have not been established. Here, we describe two...

Full description

Bibliographic Details
Main Authors: Daiji Takamoto, Hajime Sasaki, Hiroshi Kataoka, Fumihiro Kodama, Haruka Higuchi, Tetsuo Hirano, Yusuke Takada, Shigeru Harada, Hiroshi Harada, Hiroshi Tanaka
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:IJU Case Reports
Subjects:
COVID‐19
cytokine release syndrome
dexamethasone
kidney transplant recipient
tocilizumab
Online Access:https://doi.org/10.1002/iju5.12492

Internet

https://doi.org/10.1002/iju5.12492

Similar Items